Centaurus Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-752
| Closed | -$151K | – | 743 |
|
|
2023
Q1 | $151K | Buy |
752
+11
| +1% | +$2.21K | 0.01% | 744 |
|
|
2022
Q4 | $176K | Buy |
741
+18
| +2% | +$4.28K | 0.02% | 643 |
|
|
2022
Q3 | $145K | Buy |
723
+23
| +3% | +$4.61K | 0.01% | 705 |
|
|
2022
Q2 | $102K | Hold |
700
| – | – | 0.01% | 800 |
|
|
2022
Q1 | $114K | Hold |
700
| – | – | 0.01% | 827 |
|
|
2021
Q4 | $119K | Hold |
700
| – | – | 0.01% | 839 |
|
|
2021
Q3 | $132K | Hold |
700
| – | – | 0.01% | 771 |
|
|
2021
Q2 | $119K | Buy |
+700
| New | +$119K | 0.01% | 810 |
|
|
2020
Q4 | – | Sell |
-720
| Closed | -$105K | – | 772 |
|
|
2020
Q3 | $105K | Hold |
720
| – | – | 0.01% | 612 |
|
|
2020
Q2 | $107K | Buy |
+720
| New | +$107K | 0.02% | 578 |
|
|
2018
Q3 | – | Sell |
-688
| Closed | -$68K | – | 582 |
|
|
2018
Q2 | $68K | Buy |
+688
| New | +$68K | 0.01% | 834 |
|